SEC Form 4 · accession 0001106578-26-000074
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 11, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 10, 2026 | M | 9,500 | $146.03 | A | 50,013 | D | |
| Common StockF2 | Jun 10, 2026 | S | 600 | $539.1234 | D | 49,413 | D | |
| Common StockF3 | Jun 10, 2026 | S | 800 | $540.1377 | D | 48,613 | D | |
| Common StockF4 | Jun 10, 2026 | S | 852 | $541.1608 | D | 47,761 | D | |
| Common StockF5 | Jun 10, 2026 | S | 1,158 | $542.2301 | D | 46,603 | D | |
| Common StockF6 | Jun 10, 2026 | S | 824 | $543.2644 | D | 45,779 | D | |
| Common StockF7 | Jun 10, 2026 | S | 867 | $544.3288 | D | 44,912 | D | |
| Common StockF8 | Jun 10, 2026 | S | 914 | $545.0953 | D | 43,998 | D | |
| Common StockF9 | Jun 10, 2026 | S | 215 | $546.1364 | D | 43,783 | D | |
| Common StockF10 | Jun 10, 2026 | S | 385 | $547.0925 | D | 43,398 | D | |
| Common StockF11 | Jun 10, 2026 | S | 246 | $548.6341 | D | 43,152 | D | |
| Common StockF12 | Jun 10, 2026 | S | 508 | $549.7009 | D | 42,644 | D | |
| Common StockF13 | Jun 10, 2026 | S | 156 | $550.5851 | D | 42,488 | D | |
| Common StockF14 | Jun 10, 2026 | S | 90 | $551.6017 | D | 42,398 | D | |
| Common StockF15 | Jun 10, 2026 | S | 587 | $553.6384 | D | 41,811 | D | |
| Common StockF16 | Jun 10, 2026 | S | 933 | $554.5624 | D | 40,878 | D | |
| Common StockF17 | Jun 10, 2026 | S | 285 | $555.2868 | D | 40,593 | D | |
| Common StockF18 | Jun 10, 2026 | S | 80 | $557.035 | D | 40,513 | D | |
| Common Stock | holding | — | — | — | 166 | I | by Spouse | |
| Common StockF19 | holding | — | — | — | 324,443 | I | by Trust | |
| Common StockF20 | holding | — | — | — | 249,108 | I | by Trust | |
| Common StockF21 | holding | — | — | — | 45,596 | I | by Trust | |
| Common StockF22 | holding | — | — | — | 8,902 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $146.03 | Jun 10, 2026 | M | 9,500 | D | Mar 15, 2020 | Mar 15, 2027 | Common Stock | 9,500 | 59,910 | D |
Explanation of responses
- F1This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10This transaction was executed in multiple trades at prices ranging from $546.80 to $547.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $548.16 to $549.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12This transaction was executed in multiple trades at prices ranging from $549.16 to $550.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13This transaction was executed in multiple trades at prices ranging from $550.21 to $551.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14This transaction was executed in multiple trades at prices ranging from $551.21 to $552.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15This transaction was executed in multiple trades at prices ranging from $552.97 to $553.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16This transaction was executed in multiple trades at prices ranging from $554.00 to $554.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F17This transaction was executed in multiple trades at prices ranging from $555.14 to $555.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F18This transaction was executed in multiple trades at prices ranging from $557.01 to $557.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F19Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F2This transaction was executed in multiple trades at prices ranging from $538.58 to $539.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F20Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F21Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F22Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F3This transaction was executed in multiple trades at prices ranging from $539.69 to $540.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $540.72 to $541.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $541.72 to $542.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $542.72 to $543.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $543.74 to $544.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $544.76 to $545.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $545.80 to $546.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.